Rheumatoid arthritis (RA) is a debilitating autoimmune disease of global prevalence and the disease process primarily targets the synovial joints. Despite improvements in the treatment of RA over the past decade, there still is a need for new therapeutic agents that are efficacious, less expensive, and free of severe adverse reactions. Celastrus has been used in China for centuries for the treatment of rheumatic diseases. Furthermore, we previously reported that ethanol extract of Celastrus aculeatus Merr. (Celastrus) attenuates adjuvant-induced arthritis (AA) in rats. However, the mechanisms underlying the anti-arthritic activity of Celastrus have not yet been fully defined. We reasoned that microarray analysis might offer useful insights into the pathways and molecules targeted by Celastrus. We compared the gene expression profiles of the draining lymph node cells (LNC) of Celastrus-treated (Tc) versus water-treated (Tw) rats, and each group with untreated arthritic rats (TJ. LNC were restimulated with, mycobaterial heat shock protein-65 (Bhsp65). We identified 104 differentially expressed genes (DEG) (8 up regulated, 96 downregulated) when comparing Tc with To rats, in contrast to 28 (12 upregulated, 16 downregulated) when comparing Tw and To rats. Further, 20 genes (6 upregulated, 14 downregulated) were shared by both Tw and Tc groups. Thus, Celastrus treatment (Tc) significantly downregulated a large proportion of genes compared to controls (Tw). The DEG were mainly associated with the processes of immune response, cell proliferation and apoptosis, and cell signaling. These results provide novel insights into the mechanism of Celastrus anti-arthritic activity, and unravel potential therapeutic targets for arthritis.
induced arthritis (AA) in rats by Celastrus aculeatus Merr. (Celastrus) (11, 12) . However, the mechanisms underlying the anti-arthritic activity of Celastrus have not yet been fully defined.
AA can be induced in the Lewis (RT-l 1 ) rat by subcutaneous injection ofheat-killed M tuberculosis H37Ra (Mtb). Mycobacterial heat-shock protein 65 (Bhsp65) is one ofthe antigenic targets ofthe immune response in arthritic rats (13, 14) . Considering the involvement of diverse inflammatory and immune pathways in the induction and progression ofAA, we argued that microarray analysis, which can provide a snapshot of concurrent changes in the expression of a large panel of genes of interest (15) , would offer useful insights into the Celastrus-targeted pathways and molecules. To this effect, we examined by microarray analysis the effect of Celastrus treatment on the expression of defined Bhsp65-induced genes in the draining lymph node cells (LNC) of arthritic rats. The arthritogenic leukocytes are activated in the antigen-draining lymph nodes following s.c. injection of Mtb to Lewis rats. From the lymph nodes, these leukocytes migrate into the synovial joints. For this reason, the study of LNC provides invaluable information about the immune events that might be modulated by Celastrus treatment of rats.
We describe here for the first time the overall differential transcriptional changes in LNC of Celastrus-treated versus control arthritic rats. These analyses allowed us to identify genes regulated by Celastrus that might playa major role in attenuating the progression of acute AA. In addition, our results revealed new potential targets that can be further explored for the treatment of arthritis.
MATERIALS AND METHODS

Animals
Male Lewis (LEW/SsNHsd) (RT-Il) rats, 5 to 6 weeks old, were purchased from Harlan Sprague Dawley (Indianapolis, IN, USA) and housed in an accredited animal facility at the University of Maryland Baltimore (UMB). All animal handling and experimental work were carried out in accordance with the National Institutes of Health (NIH) guidelines for animal welfare, and the study was approved by the Institutional Animal Care and Use Committee (IACUC). Animals were acclimated to the holding room for at least 3 days before initiation of experimental work.
Preparation ofCelastrus for the treatment ofarthritic rats
Celastrus (ethanol extract ofCelastrus aculeatus Merr.) was prepared as described previously (11, 12) . Briefly, the powder obtained by mincing dried roots and stems of C. aculeatus was extracted for 2 h with 75% ethanol. The extract was re-extracted twice following the same procedure. The final extract was concentrated and dried. To study the anti-arthritic activity ofCelastrus, the ethanol extract was suspended in water and arthritic Lewis rats were fed at the dose of 3g1kg body weight by using the regimen described below.
Induction of adjuvant arthritis (AA) and treatment with Celastrus
AA was induced in a cohort of Lewis rats by immunizing them subcutaneously (s.c.) at the base of the tail with 2mg/rat of heat-killed M tuberculosis H37Ra (Mtb) (Difco, Detroit, Michigan) emulsified in 200 ul mineral oil (Sigma-Aldrich, St. Louis, MO). Thereafter, at the onset of arthritis, one group of rats was sacrificed (To, n= 3), whereas other two groups were subjected to treatment daily for 7 days either with Celastrus (in water, administered by gavage) (T e, n= 3) or with the vehicle (water, by gavage) (TW' n= 3). After that, these rats were sacrificed and their draining lymph node cells (LNC) (superficial inguinal, para-aortic, and popliteal) were harvested for testing.
Culture ofLNC andpreparation ofRNA LNC (5 x 10 6 cells/well) were cultured for 24 h at 37°C in a six-well plate in vitro in serum-free HL-l medium (Lonza, Walkersville, MD, USA) with or without Bhsp65 (Sug/ml). Total RNA was extracted with Trizol reagent (Invitrogen, Carlsbad, CA, USA) and purified with RNeasy Mini Kit (QiagenLtd, Crawley, UK) following the manufacturer's instructions. The concentration as well as the quality of RNA were then analyzed by the NanoDrop ND-IOOO (NanoDrop Technologies/Thermo Scientific, Wilmington, DE) and processed further on an RNA 6000 Nano LabChip kit (Agilent Technologies lnc., Palo Alto, CA, USA) using Agilent 2100 Bioanalyzer.
Gene chip hybridization
Illumina bead-based array, RatRef-12 Expression BeadChip (This chip contains over 22,000 probes based on the NCBI RefSeq database) was used to perform the whole genome expression profiling. Total RNA (50ng/~1) was used to synthesize the second strand eDNA, which was then transcribed into biotin-labeled cRNA. Purified cRNA was hybridized onto the chip (three independent experiments, i.e., 3 gene chips/group, biological replicates) according to Illumina's Direct Hybridization Assay protocol. Thereafter, the signal was scanned on
Quantitative real-time PCR (q-PCR)
The expression ofa select set ofdifferentially expressed genes (DEG) (up-/down-regulated) (Ccrl, Ccr5, CxclIO, Lpl, Socs1, and Spp 1) identified in microarray analysis was validated by quantitative real-time PCR (q-PCR) using the same RNA that was used for microarray analysis. Specific primers for the selected genes were designed according . B
to the NCBI sequence database using the software Primer Expression 2.0 and synthesized by Sigma-Aldrich (St. Louis, MO). Each RNA sample was tested in three replicates by q-PCR and the results were presented as 8% " fold change" compared to the respective baseline using the 2-M Ct method as described in our previous study (14) . 
Data acquisition and analysis
RESULTS
Mtb contains multiple components, including Bhsp65, the disease-related antigen for AA (13, 16, 17) . An immunological response to Bhsp65 has been implicated in the pathogenesis of arthritis in animals and humans (13, 16, 20) . Therefore, we investigated the molecular effects of CelastruslWater treatment of arthritic rats by testing the gene expression of the draining LNC that were restimulated in vitro with Bhsp65.
Statistical analysis
The microarray data were analyzed for determining the significance of the level of expression of DEG (mean "fold change"). For this purpose, unpaired t test corrected with Benjamin-Hochberg and p value <0.05 coupled with a fold change >2.0 was used as the cut off. The q-PCR data were presented as "fold change" and its significance was analyzed by a two-tailed Student's t test with a p value < 0.05 .
Comparative gene expression profiles of Bhsp65-restimulated LNC of CelastruslWater-treated rats versus untreated rats at onset ofarthritis (T)
To assess the Celastrus-induced changes in gene expression during the subsequent progression of arthritis following onset of the disease, we used as reference the gene expression profile of arthritic Lewis rats with AA before starting any treatment (To)' Using the 'To' group as the reference, we compared the gene expression profile each of Bhsp65-restimulated LNC of Water-treated (control) (Tw) or Celastrus-treated (experimental group) (Tc) rats to the To group of rats. Overall, the gene expression at Tctime-point was markedly different from that of Tw, each compared to To (Fig. 1) .
Specifically, a comparison of the Water-treated (T w ) vs To rats revealed 28 DEG (12 upregulated, 16 downregulated), and these DEG were mainly associated with the processes of immune response, cell proliferation and apoptosis, and signaling regulation and signal transduction. On the contrary, a comparison of the Celastrus-treated (T c ) vs To rats showed 104 DEG (8 upregulated, 96 downregulated). These DEG were related with two sub-groups of processes, one ofwhich was also found in the abovementioned Water-treated (T w ) vs To group, and the other which was evident only in the Celastrus-treated group (e.g., oxidation-reduction, metabolism, and transportation) ( Table I ). The most notable finding of the comparison of the gene expression profiles of the 3 groups of rats described above was the significant downregulation of a large proportion of DEG following Celastrus treatment compared to Water treatment, with each group compared to To'
Comparative gene expression profiles of Bhsp65-restimulated LNC of Celastrus-treated (TJ and Water-treated control (TJ rats upon completion of treatment
We then compared the gene expression of Tw and Tc groups at the completion of treatment. Celastrus-treated rats exhibited a very different gene expression profile compared to the Watertreated rats (Fig. 2) . One hundred and twenty DEG were identified in Water-fed arthritic rats compared to only 13 in Celastrus-fed rats (Table II) . Eleven DEG were shared by these two groups of rats (Fig. 2) . In control rats (T w ) , the Bhspef-induced genes were functionally associated with multiple pathways such as immune activity and regulation, cell proliferation and apoptosis, binding activity, diverse metabolic pathways, and signal transduction and regulation of signaling events. The numbers and main functional group of genes whose expression was altered following Bhsp65 restimulation were compared between the two groups (Table II, III) . Besides the main group of genes related to immune response listed in Table III , another smaller group of interesting genes listed therein is involved in lipid metabolism and regulation of signaling pathways.
In both groups, the genes involved in immune responses comprised the largest cluster among the Bhsp65-induced genes, and these genes could be further classified into three groups according to their expression level (Table III) . (a) The first group included the genes whose expression was significantly altered in Water-treated rats, but remained unchanged in Celastrus-treated rats. In the former, all genes were upregulated in their expression (Table III) except Ccrl (C-C chemokine receptor type 1), Sitl (Signaling threshold-regulating transmembrane adapter 1), Lgals3 (Galectin-3), Klrd (Natural killer cells antigen CD94), Lytidpredicted (Lymphocyte antigen 6 complex, locus D), Cd36 (CD36 molecule) and Sppl (Osteopontin). The upregulated genes are involved in costimulation (Cd40), antigen processing and presentation (e.g., Tap1, RT1-149, Psmd1), response to IFN stimulation (e.g., Ifi44, Gbp2), cell migration (Cxcll 0, Cxclll, Ccl20, Ccr5), innate immunity (e.g., Zbpl) and others (e.g., 111b, Socsl, Nampt). (b) The second group included only one gene, IL2ra, which was significantly upregulated in Celastrus-treated rats, but was unaltered in Water-treated rats. (c) The third group included 8 genes that were differentially expressed in both Celastrus-treated and Water-treated rats. All of the 8 genes in this group showed similar direction of change (upregulation) but different level of expression between the two groups of rats.
The above data indicate that Celastrus regulated multiple arthritis-related molecular responses to achieve attenuation of the disease. The most marked reduction was in the expression of Bhsp65-induced genes related to immune responses and cellular proliferation. Further, when we compared the ex vivo gene expression of LNC in medium of Celastrustreated vs water-treated rats, no significant difference in the gene expression profiles was found (data not shown). These results show that the effect of Celastrus was predominantly focused on the antigen (Bhsp65)-induced genes in arthritic rats. The gene expression data obtained from microarray analysis was validated by q-PCR using a set of6 representative genes (Ccrl, Ccr5, CxcllO, Lpl, SocsI, and SppI). The data obtained by the two methods matched well (Fig. 3, r=O. 8074, p<O.05), thus validating the specific changes revealed by microarray analysis in our study.
DISCUSSION
It has been reported by various investigators that conventionally used anti-rheumatic drugs have distinct effects on the RA-related gene expression patterns (21) (22) (23) (24) (25) (26) . Methotrexate (MTX), a diseasemodifying anti-rheumatic drug, has complex influences dominated by reversing the expression of anti-proliferative genes (22) . Glucocorticoids, like prednisolone, effectively reduce the expression of genes that are related to inflammation (21, 23) . However, there is limited information on changes in the expression of disease-related genes by natural products belonging to complementary and alternative medicine (CAM) that are being used for the treatment of arthritis in traditional systems of medicine. In this context, the present study was aimed at elucidating the molecular effects of the Chinese medicinal herb Celastrus on the expression profile ofarthritis-related, antigen (Bhsp65)-induced genes in the draining lymph node cells (LNC) of arthritic rats. Although several cell types other than lymphoid cells (as in LNC) participate in the pathogenesis of arthritis, this study is focused on the gene expression profiling of LNC. Further, Hsp65 has been invoked as the target antigen in inflammatory arthritis in RA (27) . Our results showing Celastrus-mediated suppression of Bhsp65-induced immune activity genes are consistent with the inhibition of the progression of arthritis following Celastrus treatment. These results also validated, albeit indirectly, that Bhsp65 is a key disease-related antigenic target in arthritis.
A comparison each of Celastrus-treated (Tc)/ Water-treated (Tw) group with untreated rats at the onset of AA (To) provided a broad insight into the mechanism of action of Celastrus. Using To as reference, Celastrus downregulated a large proportion of genes involved in different biological processes (Table I) . These results emphasize that Celastrus treatment suppressed the expression of genes relating to a wide range of biological processes. Thus, the anti-arthritic activity of Celastrus involved multiple pathways. Besides affecting T-cell proliferation, antigen processing and presentation, and effector immune responses, Celastrus modulated the host response to oxidation-reduction (as exemplified by the interesting set of genes: Cox8a, Etfa, Hbb, Hba-a2,MGC72973; all downregulated) as well as metabolism of lipid and glucose (as evident from altered expression of the genes Aldoa, Dhps, Vim, Upp 1, Leprotll; all down regulated).
A comparative gene expression of Tc vs Tw at the time of completion of treatment is given in Tables II  and III. Ofthe various cytokine genes examined (Table  III) , Celastrus suppressed the expression of IPN-y, a Thl cytokine in response to Bhsp65 restimulation, suggesting that the lPN-induced responses were altered by Celastrus without having a significant effect on cytokines related to Th2 or Th17 response. Additionally, IL-l~is significantly decreased by Celastrus during restimulation with Bhsp65. The chemokine CXCLlO (IP-10) showed increased expression after Bhsp65 restimulation compared to baseline in control rats, but this increase was not evident in rats treated with Celastrus (Table III) . CXCLl 0 is alO kDa protein induced by IPN-y. IPN synergizes with IL-l~or TNF-a in CXCLlO production. In this regard, inhibition of IL-l~by Celastrus might contribute to reduced production of CXCLl 0 in Celastrus-treated rats. Both CXCLI0 and its receptor CXCR3 are abundantly expressed in RA synovium and may playa role in disease pathogenesis (28, 29) . Treatment of rats with anti-CXCL 10 antibody results in the suppression of AA (30) . Taken together, the anti-arthritic activity of Celastrus might be mediated in part via downregulation of CXCLlO. In addition, the expression of CCL20 (macrophage Inflammatory Protein-3) and CCR5, which are found to be highly expressed on the synovial membrane or joint tissue of RA patients, was downregulated by Celastrus.
Amarkeddifference(l3versus 120)in the number of DEG after Bhsp65 restimulation ofLNC ofCelastrustreated versus Water-treated control rats shows that Celastrus inhibited the expression of many more genes besides those associated with immune activity. Some of the genes related with arthritis are listed in Table III . A gene of interest encodes Lpl (lipoprotein lipase; LPL). An inverse relationship between LPL and inflammatory activity in RA has been reported (31) . Our results are compatible with that study; the downregulation of Lpl was observed in control rats (Water-fed) but a relatively higher expression of Lpl was evident in Celastrus-treated rats. However, it is not clear whether the change in expression of Lpl is the cause or the result of inflammation. We also observed that Rgs 1 and Rgs2 with similar function (Table III) . Celastrus treatment relatively downregulated the expression of both Rgs1 and Rasgrp2---'predicted compared to control (Water-treatment), and this effect might terminate the G-protein-driven signaling. G protein signaling coordinates signals from a large number of hormones, neurotransmitters, chemokines, and autocrine and paracrine factors. By altering the expression of regulators (Rgs1 and Rasgrp2---'predicted) of G-protein signaling, Celastrus might attenuate arthritis. In regard to Sag, biologically, it protects cells from apoptosis and promotes growth of cells. We suggest that the downregulation of Sag expression contributes to the reduced proliferation of lymphocytes after antigenic restimulation and thereby, helps inhibit the pathogenic T-cell response in arthritis.
Increased oxidative stress has. been implicated in the pathogenesis of inflammatory, autoimmune and degenerative diseases. Accordingly, natural plant products that possess anti-oxidant and free radical-scavenging properties have been shown to provide beneficial health benefits in oxidative stress-associated diseases in experimental models (32, 33) . In this context, Celastrus and its bioactive component Celastrol have been reported to possess anti-oxidant properties, and to offer beneficial outcome in oxidative-stress-induced injury (33) (34) (35) . These findings in part provide support to our results showing that Celastrus can downregulate the above two groups of genes involved in oxidative phosphorylation and energy metabolism.
The above-mentioned results provide useful insights into the mechanism of action of Celastrus, which suppresses AA in the Lewis rat. In summary, the beneficial effects of Celastrus treatment in AA are attributable in part to the suppression of inflammation, the inhibition of proliferation of immune cells, and the regulation of pathogenic immune effector responses. Thus global gene expression analysis provided novel insights into the etiopathologic mechanisms underlying AA, and such expression profiling is expected to lead to better diagnosis, patient classification, and individualized therapy of RA.
